Vanguard Group Inc. increased its stake in Amgen Inc. by 0.3% in the third quarter, acquiring an additional 165,281 shares and now owning approximately 10.01% of the company, valued at over $15.2 billion. Amgen also reported strong financial results with EPS of $5.29, beating estimates, and raised its quarterly dividend to $2.52 per share, indicating management confidence in cash flow. The stock currently has a “Moderate Buy” rating from analysts with an average target price of $354.04.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Vanguard Group Inc. Purchases 165,281 Shares of Amgen Inc. $AMGN
Vanguard Group Inc. increased its stake in Amgen Inc. by 0.3% in the third quarter, acquiring an additional 165,281 shares and now owning approximately 10.01% of the company, valued at over $15.2 billion. Amgen also reported strong financial results with EPS of $5.29, beating estimates, and raised its quarterly dividend to $2.52 per share, indicating management confidence in cash flow. The stock currently has a “Moderate Buy” rating from analysts with an average target price of $354.04.